Stirlingshire Investments’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,900
Closed -$207K 240
2026
Q1
$207K Buy
+1,900
New +$181K 0.18% 185

Other funds holding LMAT

Stirlingshire Investments's LMAT Position: Q2 2026 in Review

Stirlingshire Investments sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 1,900 shares — an estimated $207K sold.

Stirlingshire Investments first reported a position in LMAT in Q1 2026 and held it in 1 quarter. The position peaked at $207K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Stirlingshire Investments reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Stirlingshire Investments sold 1,900 LeMaitre Vascular shares in Q2 2026, an estimated $207K.
  • Stirlingshire Investments first reported a position in LeMaitre Vascular in Q1 2026 and held it in 1 quarter.
  • Stirlingshire Investments's LeMaitre Vascular position peaked at $207K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Stirlingshire Investments's 13F filing for Q2 2026, filed 31 Jul 2026.